 |
인쇄하기
취소
|
Shinpoong’s GMP plant gets Europe’s approval
Shinpoong Phamaceutical’s new GMP plant for production of antimalarial drugs is gaining international certification.
The company said it received a final EU-GMP certification from the European Medicines Agency (EMA) on May 23.
With EU certification, the company is seeking to boost its presence in the global pharmaceutical market this year with its Pyramax (artesunate/pyronaridine).
"Sh...
The company said it received a final EU-GMP certification from the European Medicines Agency (EMA) on May 23.
With EU certification, the company is seeking to boost its presence in the global pharmaceutical market this year with its Pyramax (artesunate/pyronaridine).
"Sh...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.